Abstract
Purpose
Evaluate periodontal status of acromegalics through clinical and biochemical variables.
Methods
Demographics, hormone and metabolic variables, periodontal variables, gingival crevicular fluid (GCF) volume, and content data were collected from 30 patients with acromegaly, 30 patients with periodontitis, and 20 healthy subjects and comparatively analyzed.
Results
GH differences between acromegaly (2.56 ± 4.86) and periodontitis (0.53 ± 0.95) (p < 0.001) were statistically significant. IGF-1 was lowest at periodontitis (113.31 ± 45.01) and lower (152.11 ± 45.56) at healthy group compared with acromegalics (220.38 ± 167.62) (p < 0.05). GH and IGF-1 had positive correlation (p < 0.05). IGF-1 and CAL had negative (p < 0.01) correlation except healthy group that showed the same correlation at the opposite direction (p < 0.05). Besides similar plaque and gingival indices with periodontitis, acromegalics showed relatively less CAL and GCF volume but except CAL, all their periodontal variables were higher than healthy subjects. GCF GH and prolactin showed higher values in acromegalics while healthy subjects showed relatively high interleukin-1, -10 and carboxyterminal telopeptide of type I collagen compared with others.
Conclusion
Acromegalics have a tendency of slowed periodontal destruction with an influence of GH and IGF-1 to the inflammation- and collage metabolism-related mechanisms rather than bone-associated ones. However, this information must be confirmed with further studies exploring the mechanisms possibly bonded to others.
Similar content being viewed by others
References
A. Lavrentaki, A. Paluzzi, J.A. Wass, N. Karavitaki, Epidemiology of acromegaly: review of population studies. Pituitary 20(1), 4–9 (2017). https://doi.org/10.1007/s11102-016-0754-x
Schilbach, K., Strasburger, C. J., Bidlingmaier, M, Biochemical investigations in diagnosis and follow up of acromegaly. Pituitary 20(1), 33–45 (2017). https://doi.org/10.1007/s11102-017-0792-z
R. Zahr, M. Fleseriu, Updates in diagnosis and treatment of acromegaly. Eur. Endocrinol. 14(2), 57–61 (2018). https://doi.org/10.17925/EE.2018.14.2.57
A.P. Heaney, S. Melmed, Molecular targets in pituitary tumours. Nat. Rev. Cancer 4(4), 285–295 (2004). https://doi.org/10.1038/nrc1320
S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg, D. Clemmons, P. Chanson, E. Laws, J. Schlechte, M.L. Vance, K. Ho, A. Giustina, Acromegaly Consensus Group, Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509–1517 (2009). https://doi.org/10.1210/jc.2008-2421
L. Vilar, C.F. Vilar, R. Lyra, R. Lyra, L.A. Naves, Acromegaly: clinical features at diagnosis. Pituitary 20(1), 22–32 (2017). https://doi.org/10.1007/s11102-016-0772-8
M. Dural, G. Kabakci, N. Cinar, T. Erbas, U. Canpolat, K.M. Gurses, L. Tokgozoglu, A. Oto, E.B. Kaya, H. Yorgun, L. Sahiner, S. Dagdelen, K. Aytemir, Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 17(2), 163–170 (2014). https://doi.org/10.1007/s11102-013-0482-4
I.M. Holdaway, R.C. Rajasoorya, G.D. Gamble, Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 89(2), 667–674 (2004). https://doi.org/10.1210/jc.2003-031199
A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004). https://doi.org/10.1210/er.2002-0022
S. Dogan, A. Atmaca, S. Dagdelen, B. Erbas, T. Erbas, Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine 45(1), 114–121 (2014). https://doi.org/10.1007/s12020-013-9981-3
E. Ritvonen, E. Loyttyniemi, P. Jaatinen, T. Ebeling, L. Moilanen, P. Nuutila, R. Kauppinen-Makelin, C. Schalin-Jantti, Mortality in acromegaly: a 20-year follow-up study. Endocr. Relat. Cancer 23(6), 469–480 (2016). https://doi.org/10.1530/ERC-16-0106
A. Ciresi, M.C. Amato, R. Pivonello, E. Nazzari, L.F. Grasso, F. Minuto, D. Ferone, A. Colao, C. Giordano, The metabolic profile in active acromegaly is gender-specific. J. Clin. Endocrinol. Metab. 98(1), E51–E59 (2013). https://doi.org/10.1210/jc.2012-2896
C. Giordano, A. Ciresi, M.C. Amato, R. Pivonello, R.S. Auriemma, L.F. Grasso, A. Galluzzo, A. Colao, Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study. Pituitary 15(4), 539–551 (2012). https://doi.org/10.1007/s11102-011-0365-5
J.L. Ebersole, D. Dawson 3rd, P. Emecen-Huja, R. Nagarajan, K. Howard, M.E. Grady, K. Thompson, R. Peyyala, A. Al-Attar, K. Lethbridge, S. Kirakodu, O.A. Gonzalez, The periodontal war: microbes and immunity. Periodontol. 2000 75(1), 52–115 (2017). https://doi.org/10.1111/prd.12222
R.J. Genco, W.S. Borgnakke, Risk factors for periodontal disease. Periodontol. 2000 62(1), 59–94 (2013). https://doi.org/10.1111/j.1600-0757.2012.00457.x
P.N. Papapanou, C. Susin, Periodontitis epidemiology: is periodontitis under-recognized, over-diagnosed, or both? Periodontol. 2000 75(1), 45–51 (2017). https://doi.org/10.1111/prd.12200
American academy of periodontology task force report on the update to the 1999 classification of periodontal diseases and conditions. J Periodontol. 86(7), 835–838 (2015). https://doi.org/10.1902/jop.2015.157001
I. Kreitschmann-Andermahr, J. Kohlmann, B. Kleist, U. Hirschfelder, R. Buslei, M. Buchfelder, S. Siegel, Oro-dental pathologies in acromegaly. Endocrine 60(2), 323–328 (2018). https://doi.org/10.1007/s12020-018-1571-y
A. Ben-Shlomo, S. Melmed, Acromegaly. Endocrinol. Metab. Clin. North Am. 37(1), 101–122 (2008). https://doi.org/10.1016/j.ecl.2007.10.002.
H. Serinsoz, M.E. Ertorer, S. Bascil, O. Bakiner, E. Bozkirli, N.B. Tutuncu, Low prevalence of periodontitis in acromegaly: growth hormone may exert a protective effect. Turk. J. Endocrinol. Metab. 19(2), 42–48 (2015). https://doi.org/10.4274/tjem.2687
D.L. Lima, R.M. Montenegro Jr., A.P. Vieira, M.F. Albano, D.M. Rego, Absence of periodontitis in acromegalic patients. Clin. Oral. Invest. 13(2), 165–169 (2009). https://doi.org/10.1007/s00784-008-0216-6
P. Chanson, S. Salenave, Acromegaly. Orphanet J. Rare Dis. 3, 17 (2008). https://doi.org/10.1186/1750-1172-3-17
A.N. Harb, B. Holtfreter, N. Friedrich, H. Wallaschofski, M. Nauck, M. Albers, P. Meisel, R. Biffar, T. Kocher, Association between the insulin-like growth factor axis in serum and periodontitis in the study of health in pomerania: an exploratory study. J. Clin. Periodontol. 39(10), 931–939 (2012). https://doi.org/10.1111/j.1600-051X.2012.01935.x
A. Juul, Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 13(4), 113–170 (2003)
J.I. Jones, D.R. Clemmons, Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16(1), 3–34 (1995). https://doi.org/10.1210/edrv-16-1-3
W. Gotz, D. Kunert, D. Zhang, A. Kawarizadeh, S. Lossdorfer, A. Jager, Insulin-like growth factor system components in the periodontium during tooth root resorption and early repair processes in the rat. Eur. J. Oral. Sci. 114(4), 318–327 (2006). https://doi.org/10.1111/j.1600-0722.2006.00381.x
A.C. Sant’Ana, M.M. Marques, T.E. Barroso, E. Passanezi, M.L. de Rezende, Effects of TGF-beta1, PDGF-BB, and IGF-1 on the rate of proliferation and adhesion of a periodontal ligament cell lineage in vitro. J. Periodontol. 78(10), 2007–2017 (2007). https://doi.org/10.1902/jop.2007.070119
H.L. Levin, Some dental aspects of endocrine diseases. Oral. Surg. Oral. Med. Oral. Pathol. 19, 466–477 (1965)
K.S. Mine, C. Nakagawa, T. Hiramoto, K. Murata, T. Tagawa, Gingivitis in acromegaly successfully treated with a growth hormone secretion inhibitor. Endocrinologist 17(1), 20–22 (2007). https://doi.org/10.1097/01.ten.0000257447.32994.da
S. Bascil, H. Serinsoz, N.B. Tutuncu, Acromegaly is protective for periodontal tissue—advanced chronic periodontitis is rare in acromegalics. Bratisl. Lek. Listy 115(9), 588–592 (2014)
J. Meyle, I. Chapple, Molecular aspects of the pathogenesis of periodontitis. Periodontol. 2000 69(1), 7–17 (2015). https://doi.org/10.1111/prd.12104
J. Moock, C. Albrecht, N. Friedrich, H. Volzke, M. Nauck, M. Koltowska-Haggstrom, T. Kohlmann, H. Wallaschofski, Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania. Eur. J. Endocrinol. 160(1), 17–24 (2009). https://doi.org/10.1530/EJE-08-0738
G.C. Armitage, Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4(1), 1–6 (1999). https://doi.org/10.1902/annals.1999.4.1.1
B. Rai, J. Kaur, S.C. Anand, Possible relationship between periodontitis and dementia in a North Indian old age population: a pilot study. Gerodontology 29(2), e200–e205 (2012). https://doi.org/10.1111/j.1741-2358.2010.00441.x
J. Silness, H. Loe, Periodontal disease in pregnancy. II. correlation between oral hygiene and periodontal condtion. Acta Odontol. Scand. 22, 121–135 (1964)
H. Loe, J. Silness, PeriodontAl Disease in Pregnancy. I. prevalence and severity. Acta Odontol. Scand. 21, 533–551 (1963)
D. Yilmaz, F. Caglayan, E. Buber, E. Kononen, Y. Aksoy, U.K. Gursoy, G.N. Guncu, Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis. Clin. Oral. Invest. 22(5), 2135–2140 (2018). https://doi.org/10.1007/s00784-018-2469-z
H. Li, P.M. Bartold, C.Z. Zhang, R.W. Clarkson, W.G. Young, M.J. Waters, Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology 139(9), 3855–3862 (1998). https://doi.org/10.1210/endo.139.9.6211
H. Li, P.M. Bartold, W.G. Young, Y. Xiao, M.J. Waters, Growth hormone induces bone morphogenetic proteins and bone-related proteins in the developing rat periodontium. J. Bone Min. Res. 16(6), 1068–1076 (2001). https://doi.org/10.1359/jbmr.2001.16.6.1068
A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29(5), 535–559 (2008). https://doi.org/10.1210/er.2007-0036
H.R. Haase, S. Ivanovski, M.J. Waters, P.M. Bartold, Growth hormone regulates osteogenic marker mRNA expression in human periodontal fibroblasts and alveolar bone-derived cells. J. Periodontal Res. 38(4), 366–374 (2003)
J.G. Caton, G. Armitage, T. Berglundh, I.L.C. Chapple, S. Jepsen, K.S. Kornman, B.L. Mealey, P.N. Papapanou, M. Sanz, M.S. Tonetti, A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J. Periodontol. 89(Suppl 1), 1–8 (2018). https://doi.org/10.1002/JPER.18-0157
F. Boabaid, J.E. Berry, A.J. Koh, M.J. Somerman, L.K. McCcauley, The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. J. Periodontol. 75(9), 1247–1254 (2004). https://doi.org/10.1902/jop.2004.75.9.1247
S. Feitosa Dda, B. Bezerra Bde, G.M. Ambrosano, F.H. Nociti, M.Z. Casati, E.A. Sallum, S. de Toledo, Thyroid hormones may influence cortical bone healing around titanium implants: a histometric study in rats. J. Periodontol. 79(5), 881–887 (2008). https://doi.org/10.1902/jop.2008.070466
A. Ishisaka, T. Ansai, I. Soh, K. Inenaga, A. Yoshida, C. Shigeyama, S. Awano, T. Hamasaki, K. Sonoki, Y. Takata, T. Takehara, Association of salivary levels of cortisol and dehydroepiandrosterone with periodontitis in older Japanese adults. J. Periodontol. 78(9), 1767–1773 (2007). https://doi.org/10.1902/jop.2007.070044
G. Rohini, S. Kalaivani, V. Kumar, S.A. Rajasekar, J. Tuckaram, V. Pandey, Estimation and comparison of serum cortisol levels in periodontally diseased patients and periodontally healthy individuals: a clinical-biochemical study. J. Pharm. Bioallied Sci. 7(Suppl 2), S457–S460 (2015). https://doi.org/10.4103/0975-7406.163501
M. Morishita, M. Miyagi, Y. Iwamoto, Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J. Periodontol. 70(7), 757–760 (1999). https://doi.org/10.1902/jop.1999.70.7.757
A.M. da Silva, H.N. Newman, D.A. Oakley, Psychosocial factors in inflammatory periodontal diseases. a review. J. Clin. Periodontol. 22(7), 516–526 (1995)
T. Breivik, P.K. Opstad, P. Gjermo, P.S. Thrane, Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur. J. Oral. Sci. 108(2), 115–122 (2000)
A.M. Monteiro da Silva, D.A. Oakley, H.N. Newman, F.S. Nohl, H.M. Lloyd, Psychosocial factors and adult onset rapidly progressive periodontitis. J. Clin. Periodontol. 23(8), 789–794 (1996)
R. Mengel, M. Bacher, L. Flores-De-Jacoby, Interactions between stress, interleukin-1beta, interleukin-6 and cortisol in periodontally diseased patients. J. Clin. Periodontol. 29(11), 1012–1022 (2002)
N.B. Tutuncu, T. Erbas, Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender. Exp. Clin. Endocrinol. Diabetes 112(6), 328–332 (2004). https://doi.org/10.1055/s-2004-820913
A. Cohen, D.W. Dempster, R. Muller, X.E. Guo, T.L. Nickolas, X.S. Liu, X.H. Zhang, A.J. Wirth, G.H. van Lenthe, T. Kohler, D.J. McMahon, H. Zhou, M.R. Rubin, J.P. Bilezikian, J.M. Lappe, R.R. Recker, E. Shane, Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos. Int. 21(2), 263–273 (2010). https://doi.org/10.1007/s00198-009-0945-7
F.F. Ozer, S. Dagdelen, T. Erbas, Relation of RANKL and OPG levels with bone resorption in patients with acromegaly and prolactinoma. Horm. Metab. Res. 50(7), 562–567 (2018). https://doi.org/10.1055/a-0630-1529
H. Hasturk, A. Kantarci, Activation and resolution of periodontal inflammation and its systemic impact. Periodontol. 2000 69(1), 255–273 (2015). https://doi.org/10.1111/prd.12105
R. Pivonello, R.S. Auriemma, L.F. Grasso, C. Pivonello, C. Simeoli, R. Patalano, M. Galdiero, A. Colao, Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1), 46–62 (2017). https://doi.org/10.1007/s11102-017-0797-7
M. Mercado, B. Gonzalez, G. Vargas, C. Ramirez, A.L. de los Monteros, E. Sosa, P. Jervis, P. Roldan, V. Mendoza, B. Lopez-Felix, G. Guinto, Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J. Clin. Endocrinol. Metab. 99(12), 4438–4446 (2014). https://doi.org/10.1210/jc.2014-2670
K.J. Joshipura, F.J. Munoz-Torres, B.A. Dye, B.G. Leroux, M. Ramirez-Vick, C.M. Perez, Longitudinal association between periodontitis and development of diabetes. Diabetes Res. Clin. Pr. 141, 284–293 (2018). https://doi.org/10.1016/j.diabres.2018.04.028
D.M. Shearer, W.M. Thomson, J.M. Broadbent, J. Mann, R. Poulton, Periodontitis is not associated with metabolic risk during the fourth decade of life. J. Clin. Periodontol. 44(1), 22–30 (2017). https://doi.org/10.1111/jcpe.12641
T. Kocher, J. Konig, W.S. Borgnakke, C. Pink, P. Meisel, Periodontal complications of hyperglycemia/diabetes mellitus: epidemiologic complexity and clinical challenge. Periodontol. 2000 78(1), 59–97 (2018). https://doi.org/10.1111/prd.12235
M. Bondanelli, M.R. Ambrosio, E.C. degli Uberti, Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4(4), 239–249 (2001)
Acknowledgements
The authors express their gratitude to Cigdem Gungor from Medeniyet University for the statistical analyses and Cagman Tan for his efforts in biochemical analysis of gingival crevicular fluid samples.
Funding
The study was funded by Hacettepe University Scientific Research Committee (grant number: THD-2015-7584).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Hacettepe University Local Ethics Committee, date: Mar 04, 2015; no: GO15/173-08) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ozdemir, Y., Keceli, H.G., Helvaci, N. et al. The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients. Endocrine 66, 622–633 (2019). https://doi.org/10.1007/s12020-019-02060-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02060-2